cbdMD, Inc.
YCBDdata completeness 88%10 fiscal years on filecbdMD, Inc. earns about -132% on invested capital, and has bought back 93% of its shares over 5 years. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $47.3M1 | $37.1M2 | $25.1M3 | $19.9M4 | $19.2M4 |
| Net income | −$23.4M5 | −$70.1M6 | −$22.9M7 | −$3.7M8 | −$2.04M8 |
| Operating cash flow | −$14.1M9 | −$15M10 | −$4.3M11 | −$352,79212 | −$1.45M12 |
| Capital expenditure | $342,01313 | $688,68014 | $297,54915 | $190,01516 | $184,17216 |
| Free cash flow (derived) | −$14.4M9 | −$15.7M10 | −$4.6M11 | −$542,80712 | −$1.64M12 |
| Total debt | $108,98517 | $125,49118 | $918 | — | — |
| Cash & equivalents | $26.4M19 | $6.72M20 | $1.8M21 | $2.45M22 | $2.26M22 |
| Diluted shares | 54.9M | 1.3M | 2.0M | 539,069 | 4.0M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $17.96 of net worth that earned you −$5.07 and generated −$4.07 of cash last year.
It earned an average -132% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is down 93% over 5 years — management has been buying back stock, quietly handing owners a bigger slice. Total debt has fallen 100% — deleveraging.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K · period ending 2021-09-30 · accession 0001437749-22-029136 (RevenueFromContractWithCustomerIncludingAssessedTax)
- 10-K · period ending 2022-09-30 · accession 0001437749-23-035228 (RevenueFromContractWithCustomerIncludingAssessedTax)
- 10-K · period ending 2023-09-30 · accession 0001437749-24-037840 (RevenueFromContractWithCustomerIncludingAssessedTax)
- 10-K · period ending 2024-09-30 · accession 0001437749-25-038435 (RevenueFromContractWithCustomerIncludingAssessedTax)
- 10-K · period ending 2021-09-30 · accession 0001437749-22-029136 (NetIncomeLoss)
- 10-K · period ending 2022-09-30 · accession 0001437749-23-035228 (NetIncomeLoss)
- 10-K · period ending 2023-09-30 · accession 0001437749-24-037840 (NetIncomeLoss)
- 10-K · period ending 2024-09-30 · accession 0001437749-25-038435 (NetIncomeLoss)
- 10-K · period ending 2021-09-30 · accession 0001437749-22-029136 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-09-30 · accession 0001437749-23-035228 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-09-30 · accession 0001437749-24-037840 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2024-09-30 · accession 0001437749-25-038435 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2021-09-30 · accession 0001437749-22-029136 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-09-30 · accession 0001437749-23-035228 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-09-30 · accession 0001437749-24-037840 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2024-09-30 · accession 0001437749-25-038435 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2021-09-30 · accession 0001437749-22-029136 (LongTermDebtNoncurrent)
- 10-K · period ending 2022-09-30 · accession 0001437749-23-035228 (LongTermDebtNoncurrent)
- 10-K · period ending 2021-09-30 · accession 0001437749-22-029136 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-09-30 · accession 0001437749-23-035228 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-09-30 · accession 0001437749-24-037840 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-09-30 · accession 0001437749-25-038435 (CashAndCashEquivalentsAtCarryingValue)